FIELD: organic chemistry, antibiotics, chemical technology. SUBSTANCE: invention relates to new intermediate derivatives of cephalosporin of the formula (IA) wherein: a) Ra means hydrogen atom or silyl group; Rb means group of the formula -ORe wherein Re means hydrogen atom or alkyl; Rc and Rd mean in common a bond; or b) Ra and Rb mean hydrogen atom or silyl group; Rb and Rc mean in common imino-group of the formula = N-Y wherein Y means phenyl; or c) Rd means hydrogen atom or silyl group; Ra means hydrogen atom if Rd means hydrogen atom; either Ra means hydrogen atom or silyl group if Rd means silyl group; Rb and Rc mean in common oxo-group; silyl group means tri(lower alkyl)silyl group; in free form or as a salt as an intermediate substance for preparing cephalosporins. Invention relates to method for preparing cephalosporin that involves: 1) interaction of compound of the formula (1A) wherein R means silyl group with compound of the formula (XI) or with compound of the formula (XII) wherein R5/ and R6 are similar or different and mean hydrogen atom or organic group; either R5 and R6 mean in common substituted or unsubstituted ring; R10 means aryl or lower alkyl; Cat+ means alkaline metal cation or protonated form of strong organic base to form compound of the formula (XIII) wherein R5, R6 and R are given above; 2) desilylation of compound of the formula (XIII) to form compound of the formula (VI) wherein R5 and R6 are similar or different and mean hydrogen atom or organic group; either R5 and R6 mean in common substituted or unsubstituted ring; 3) conversion of compound of the formula (VI) to cephalosporin. Invention provides preparing new intermediate derivatives of cephalosporin. EFFECT: improved preparing method. 7 cl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
INTERMEDIATE DERIVATIVE OF CEPHALOSPORIN AND METHOD OF SYNTHESIS OF CEPHALOSPORIN | 1995 |
|
RU2150471C1 |
THIAZOLIDINONE COMPOUNDS AND USE THEREOF FOR TREATING MENTAL OR NEUROLOGICAL DISORDERS AND INFLAMMATION, PARTICULARLY NEUROINFLAMMATION | 2015 |
|
RU2734253C2 |
OBESITY TREATMENT | 2019 |
|
RU2822679C2 |
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2019 |
|
RU2815647C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
MACROCYCLIC SERINE PROTEASE INHIBITORS | 2009 |
|
RU2490272C2 |
AZOLE AND THIAZOLE DERIVATIVES AND USE THEREOF | 2006 |
|
RU2436779C2 |
CEPHALOSPORIN DERIVATIVES AND PHARMACOLOGICALLY ACCEPTABLE NON-TOXIC SALTS, PHYSIOLOGICALLY HYDROLYSABLE ESTERS, SYN-ISOMERS AND OPTICAL ISOMERS, AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2091384C1 |
ANTIBACTERIAL CEPHALOSPORINS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1996 |
|
RU2183212C2 |
CARBAZOLE COMPOUNDS AND THERAPEUTIC USE OF COMPOUNDS | 2009 |
|
RU2497807C2 |
Authors
Dates
2004-03-10—Published
1995-04-24—Filed